NASDAQ:AVRO
AVROBIO Inc Stock News
$1.26
+0.0100 (+0.80%)
At Close: May 08, 2024
AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Friday, 04'th Dec 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announc
AVROBIO Announces Pricing of Underwritten Public Offering of $75 Million of Common Stock
10:06pm, Thursday, 19'th Nov 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (NASDAQ: AVRO), a leading clinical-stage gene therapy company, today announced the pricing of an underwritten public offering of 5,000,000 sh
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announc
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Friday, 06'th Nov 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announc
Online Investment Platform Offering Shares Of 1937 Heisman Trophy, Other Sports Memorabilia
12:00am, Friday, 16'th Oct 2020
The 1937 Heisman Trophy is being offered via Rally Rd., an online investment platform. Any U.S. adult with a Social Security number and bank account can buy shares for $46 apiece.
AVROBIO Expands Lentiviral Gene Therapy Pipeline with Program for Hunter Syndrome
12:00am, Monday, 05'th Oct 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today an
Protalix Could Claim Substantial Global Market Share In Fabry Disease (NYSEMKT:PLX)
06:54am, Thursday, 01'st Oct 2020
Strong need for improved enzyme replacement therapies. Protalix's deliberately engineered ERT appears to fill this unmet need.
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today an
AVROBIO (AVRO) Presents At 18th Annual Global Healthcare Virtual Conference - Slideshow
01:51pm, Monday, 14'th Sep 2020
The following slide deck was published by AVROBIO, Inc. in conjunction with this event..
AVROBIO (AVRO) Investor Presentation - Slideshow
10:56am, Friday, 11'th Sep 2020
The following slide deck was published by AVROBIO, Inc. in conjunction with this event..
Restaurant chain Chilango sold in deal that safeguards 130 jobs
12:47pm, Thursday, 27'th Aug 2020
A rescue deal for restaurant chain Chilango has been agreed in a sale that involves most of the estate remaining open. Investment group RD Capital Partners (RDCP), run by founders Sameer Rizvi and Iry
AVROBIO (AVRO) Presents At 2020 Wedbush PacGrow Healthcare Conference - Slideshow
06:02pm, Thursday, 13'th Aug 2020
The following slide deck was published by AVROBIO, Inc. in conjunction with this event..
Did Hedge Funds Make The Right Call On AVROBIO, Inc. (AVRO) ?
01:41pm, Wednesday, 12'th Aug 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11:00am, Friday, 07'th Aug 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the company has granted non-statutory
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12:00am, Friday, 07'th Aug 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today an
